Jahr Robert Charles

CIK: 0002076177•Chief Executive Officer

Officer

Primary company: Outlook Therapeutics, Inc. (OTLK)

Jahr Robert Charles is a corporate insider (Chief Executive Officer) at Outlook Therapeutics, Inc. (OTLK) filing SEC Form 4 transactions. 4 transactions. Source: SEC EDGAR.

Total Transactions

Total Buy Value

Total Sell Value

Net Activity

Last Transaction

Aug 2026

Companies

Transaction History

Filter:

Source: SEC EDGAR Form 4 insider transaction filings.

Company	Type	Shares	Price	Value	Shares After	Date	SEC
Outlook Therapeutics, Inc. OTLK	Purchase	151,515	$1.10	$167K	151,515	8/14/2026 Filed: 8/14/2026	Filing →
Outlook Therapeutics, Inc. OTLK	Purchase	151,515	-	-	151,515	8/14/2026 Filed: 8/14/2026	Filing →
Outlook Therapeutics, Inc. OTLK	Award	100,000	$1.43	$143K	100,000	7/21/2026 Filed: 7/21/2026	Filing →
Outlook Therapeutics, Inc. OTLK	Award	800,000	-	-	800,000	7/1/2025 Filed: 7/9/2025	Filing →

Outlook Therapeutics, Inc.

OTLK

Type

Purchase

151,515

Price

$1.10

Value

$167K

Outlook Therapeutics, Inc.

OTLK

Type

Purchase

151,515

Price

Value

Outlook Therapeutics, Inc.

OTLK

Type

Award

100,000

Price

$1.43

Value

$143K

Outlook Therapeutics, Inc.

OTLK

Type

Award

800,000

Price

Value

AI Agent

Try asking...